The transactivation process occurs rapidly after adding NTS to cancer cells, and when tyrosine1068 of the EGFR is phosphorylated, the MEK/ERK pathway is activated, leading to increased cancer cellular proliferation. Here, MAP2K7 is linked to cancer.